首页> 外文期刊>Vascular and endovascular surgery >Comparison of Ultrasound-Accelerated Versus Multi-Hole Infusion Catheter-Directed Thrombolysis for the Treatment of Acute Limb Ischemia
【24h】

Comparison of Ultrasound-Accelerated Versus Multi-Hole Infusion Catheter-Directed Thrombolysis for the Treatment of Acute Limb Ischemia

机译:超声加速与多孔输注导管导向溶栓的比较治疗急性肢体缺血

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Thrombolytic therapy is widely used in the treatment of arterial occlusions causing acute limb ischemia (ALI); however, knowledge regarding the efficacy of the different catheter systems available is scarce. The objective of this study was to compare the safety and efficacy of 2 catheter-directed infusion systems for intra-arterial thrombolysis in the setting of ALI. Methods: A retrospective analysis was conducted to study all catheter-directed thrombolysis procedures performed over 32 months in patients diagnosed with ALI. Patients with thrombosis in both native arteries and bypass grafts were included. Patients with contraindications to thrombolysis, or those receiving thrombolysis for deep venous thrombosis, were excluded. The duration of thrombolysis, amount of thrombolytic agent, and technical success rate were recorded. Technical success was defined as complete or near-complete resolution of thrombus burden, allowing for further intervention. Data were stratified to include location of thrombus, procedural complications, mortality, and rates of limb loss. Results: Ninety-one patients met inclusion criteria. Among them, Uni-Fuse and EKOS catheters were used in 69 and 22 patients, respectively. The mean age of the population was 71 (standard deviation [SD]: +/- 1.5) for patients treated with the EKOS catheter and 70 years (SD: +/- 2.6) for patients receiving thrombolysis with Uni-Fuse. There was no significant difference in the mean infusion duration (1.65 vs 1.9 days), volume of tissue plasminogen activator (44.6 vs 48.2 mg), or technical success rate (72% vs 86%) between the Uni-Fuse and EKOS cohorts (P > .3). Furthermore, there was no difference in major limb loss or compartment syndrome between each group (P > .4). The overall complication rate was 14% in both groups, with a 30-day mortality rate of 4% when treated with either catheter system. Conclusion: This study suggests that a standard multi-hole infusion catheter demonstrates similar clinical safety and efficacy as the ultrasound-accelerated EKOS system in the treatment of ALI.
机译:目的:溶栓治疗广泛用于治疗导致急性肢体缺血(ALI)的动脉闭塞;然而,关于可用的不同导管系统的功效的知识是稀缺的。本研究的目的是比较2个导管导向输液系统的安全性和功效在Ali的凝固中进行动脉内溶栓。方法:进行回顾性分析,以研究患有Ali的患者32个月内进行的所有导管导向的溶栓手术。包括血栓形成血栓形成和旁路移植物的患者。排除了对溶栓的禁忌症的患者,或接受深静脉血栓形成的接受溶栓,被排除在外。记录了溶栓,溶栓剂量和技术成功率的持续时间。技术成功被定义为血栓负担的完整或接近完全解决,允许进一步干预。分层数据包括血栓,程序并发症,死亡率和肢体损失率的位置。结果:901名患者符合纳入标准。其中,分别在69例和22名患者中使用单熔丝和EKOS导管。对于患有EKOS导管和70岁(SD:+/- 2.6)治疗的患者,患者的平均年龄为71(标准差[SD]:+/- 1.5),用于使用单熔丝接受溶栓溶解的患者。平均输注持续时间(1.65 vs 1.9天),组织纤溶酶原激活剂的体积(44.6 vs 48.2mg),或在UNI-FUSE和EKOS队列之间的技术成功率(72%Vs 86%)(P > .3)。此外,每组之间的主要肢体损失或隔室综合征没有差异(P> .4)。两组整体并发症率为14%,用导管系统处理时,30天死亡率为4%。结论:本研究表明,标准的多孔输注导管显示出类似于Ali的超声加速EKOS系统的临床安全性和功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号